In 2025, the Peru market reported a revenue of USD 1.54 billion.
As per our industry forecasts, the Peru Infusion Services Market will reach USD 5.00 billion by 2033, with a projected CAGR of 15.9% during the forecast period.
Infrastructure upgrades in Lima are strengthening infusion chair availability, gradually improving access to oncology biologics within public referral centers.
Peruvian Ministry of Health cancer surveillance data indicate upward diagnostic trends, supporting sustained systemic therapy demand.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]